| A meta-analysis of serious adverse events reported with exenatide and liraglutide: Acute pancreatitis and cancer C Alves, F Batel-Marques, AF Macedo Diabetes Research and Clinical Practice, 2012 | 214 | 2012 |
| The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer–a systematic review D Mendes, C Alves, N Afonso, F Cardoso, JL Passos-Coelho, L Costa, ... Breast Cancer Research 17, 1-14, 2015 | 206 | 2015 |
| Number needed to treat (NNT) in clinical literature: an appraisal D Mendes, C Alves, F Batel-Marques BMC medicine 15, 1-13, 2017 | 150 | 2017 |
| Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis C Alves, D Mendes, FB Marques European journal of clinical pharmacology 75, 1431-1443, 2019 | 103 | 2019 |
| Prevalence of undiagnosed hypothyroidism in Europe: a systematic review and meta-analysis D Mendes, C Alves, N Silverio, FB Marques European thyroid journal 8 (3), 130-143, 2019 | 92 | 2019 |
| A systematic review of observational studies evaluating costs of adverse drug reactions F Batel Marques, A Penedones, D Mendes, C Alves ClinicoEconomics and outcomes research, 413-426, 2016 | 79 | 2016 |
| Nurses' spontaneous reporting of adverse drug reactions: expert review of routine reports D Mendes, C Alves, F Batel Marques Journal of Nursing Management 22 (3), 322-330, 2014 | 44 | 2014 |
| Multiple drug exposure as a risk factor for the seriousness of adverse drug reactions AF Macedo, C Alves, N Craveiro, FB Marques Journal of nursing management 19 (3), 395-399, 2011 | 44 | 2011 |
| Apixaban and Rivaroxaban Safety After Hip and Knee Arthroplasty: A Meta-Analysis C Alves, F Batel-Marques, AF Macedo Journal of Cardiovascular Pharmacology and Therapeutics, 2011 | 43 | 2011 |
| Data sources on drug safety evaluation: a review of recent published meta-analyses C Alves, F Batel-Marques, AF Macedo Pharmacoepidemiology and Drug Safety 21 (1), 21-33, 2011 | 40 | 2011 |
| Sources of information used by regulatory agencies on the generation of drug safety alerts C Alves, AF Macedo, FB Marques European journal of clinical pharmacology 69, 2083-2094, 2013 | 36 | 2013 |
| Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events D Mendes, C Alves, F Batel‐Marques Journal of clinical pharmacy and therapeutics 39 (3), 307-313, 2014 | 34 | 2014 |
| A systematic review and meta‐analysis of the association between systemic fluoroquinolones and retinal detachment C Alves, A Penedones, D Mendes, F Batel Marques Acta ophthalmologica 94 (5), e251-e259, 2016 | 32 | 2016 |
| The role of disproportionality analysis of pharmacovigilance databases in safety regulatory actions: a systematic review P Dias, A Penedones, C Alves, C F Ribeiro, F B Marques Current drug safety 10 (3), 234-250, 2015 | 31 | 2015 |
| The risk of infections associated with JAK inhibitors in rheumatoid arthritis: a systematic review and network meta-analysis C Alves, A Penedones, D Mendes, FB Marques JCR: Journal of Clinical Rheumatology 28 (2), e407-e414, 2022 | 29 | 2022 |
| Number needed to harm in the post‐marketing safety evaluation: results for rosiglitazone and pioglitazone D Mendes, C Alves, F Batel‐Marques Pharmacoepidemiology and Drug Safety 24 (12), 1259-1270, 2015 | 27 | 2015 |
| Benefit–risk of therapies for relapsing–remitting multiple sclerosis: testing the number needed to treat to benefit (NNTB), number needed to treat to harm (NNTH) and the … D Mendes, C Alves, F Batel-Marques CNS drugs 30, 909-929, 2016 | 24 | 2016 |
| Pharmacovigilance in Portugal: Activity of the central pharmacovigilance unit F Batel-Marques, D Mendes, C Alves, A Penedones, P Dias, A Martins, ... Acta medica portuguesa 28 (2), 222-232, 2015 | 23 | 2015 |
| Safety monitoring of ophthalmic biologics: a systematic review of pre-and postmarketing safety data A Penedones, D Mendes, C Alves, F Batel Marques Journal of ocular pharmacology and therapeutics 30 (9), 729-751, 2014 | 21 | 2014 |
| Statins and risk of cataracts: A systematic review and meta‐analysis of observational studies C Alves, D Mendes, F Batel Marques Cardiovascular Therapeutics 36 (6), e12480, 2018 | 19 | 2018 |
